Investigate the application of postoperative ctDNA-based molecular residual disease detection in monitoring tumor recurrence in patients with non-small cell lung cancer——A retrospective study of ctDNA

PURPOSE: To evaluate whether postoperative circulating tumor DNA (ctDNA) in plasma of patients with non-small cell lung cancer (NSCLC) can be used as a biomarker for early detection of molecular residual disease (MRD) and prediction of postoperative recurrence. METHODS: This study subjects were eval...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xuefei, Zhang, Youguo, Zhang, Shanli, Wang, Sha, Yang, Peng, Liu, Changhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10115944/
https://www.ncbi.nlm.nih.gov/pubmed/37091156
http://dx.doi.org/10.3389/fonc.2023.1098128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10115944/
https://www.ncbi.nlm.nih.gov/pubmed/37091156
http://dx.doi.org/10.3389/fonc.2023.1098128

Ejemplares similares